Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 20 Nov 2025 for Lexeo Therapeutics, Inc., €3,087.
Filing timeline
BuySaleTai Sandi See
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Tai Sandi See: trading record in brief
Tai Sandi See discloses dealings in Lexeo Therapeutics, Inc. to SEC (Form 4). We count 9 filings; the first trade dates from 7 January 2025 and the latest from 18 November 2025.
Every open-market trade on record is a sale: 6 sales worth €42k. Other entries cover 3 share grants.
The newest entry dates from 20 November 2025: an open-market sale of €3,087, in Lexeo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tai Sandi See
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
386 shares@ US$9.2712.1% of flowCommon StockSEC:0002009350-25-000005:0
10,890 shares0Common StockSEC:0002009350-25-000003:0
382 shares@ US$4.6686.0% of flowCommon StockSEC:0001415889-25-022468:0
367 shares@ US$2.7743.6% of flowCommon StockSEC:0001415889-25-013816:0
5,720 shares@ US$2.6153.8% of flowCommon StockSEC:0001415889-25-010501:0
1,486 shares@ US$4.41324.6% of flowCommon StockSEC:0001415889-25-005110:0
38,750 shares0Common StockSEC:0001415889-25-001284:0
7 of 7 declarations
